On June 29 Vitrolife announced that the company had entered into an agreement to acquire 100% ownership in Cryo Management Ltd. Vitrolife has now completed the transaction and Cryo Management Ltd is now a part of Vitrolife.
Cryo Management Ltd is one of the world’s leading players within time-lapse for IVF, developer of Primo Vision time-lapse embryo monitoring system. The company has approximately 20 employees and is based in Hungary. The acquisition was completed under essentially the same conditions as were communicated on June 29.
“We are pleased to be able to welcome our new colleagues within Cryo to the Vitrolife Group. There continues to be great and increasing interest in the market for the company’s product for the monitoring of embryos, Primo Vision, and we look forward to being able to offer this world-leading product to current and new customers,” says Thomas Axelsson, CEO.
October 4, 2012
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Queries should be addressed to:
Thomas Axelsson, CEO, phone 46 31 721 80 01
Mikael Engblom, CFO, phone 46 31 721 80 14
Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on October 4, 2012 at 4:30 p.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.